
Ailsa Craig
Ailsa Craig has been the lead portfolio manager of International Biotechnology Trust (IBT) since 2021.
Ailsa has managed IBT since 2006. She began her career at Insight Investment / Rothschild Asset Management before joining Baring Asset Management as a research analyst. She holds a BSc (Hons) in Biology from the University of Manchester, the IMC and the Securities Institute Diploma.
Latest articles by Ailsa Craig
-
Three biotech stocks to buy now
Tips Professional investors Ailsa Craig and Marek Poszepczynski of the International Biotechnology Trust pick three of their favourite biotech stocks to buy now.
By Ailsa Craig Published
Tips -
Where to find the pick of the bunch in biotech stocks
Opinion Professional investor Ailsa Craig picks three biotech stocks generating revenues and profits, and which have long-term patent protection.
By Ailsa Craig Published
Opinion -
Three stocks to profit from the boom in pharma M&A
Opinion Ailsa Craig picks three stocks that should capitalise on the M&A trend in the pharmaceutical sector, either as potential targets or as well-established acquirers of other rivals.
By Ailsa Craig Published
Opinion -
Three biotech merger targets to buy now
Opinion Professional investor Ailsa Craig picks three biotech stocks that are ripe for takeover.
By Ailsa Craig Published
Opinion